Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy

Journal of the Chinese Medical Association

Volumn 78, Issue 8, 2015, Pages 438-445

  Chou, Yi Sheng ^a,b,c   Yang, Muh Hwa ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c LOTUNG POH AI HOSPITAL   (Taiwan)

Author keywords

Epithelial mesenchymal transition; Hematological malignancy; Solid tumor; Transcription factor

Indexed keywords

BMI1 PROTEIN; DISTAL LESS HOMEOBOX GENE 4; FORKHEAD TRANSCRIPTION FACTOR; PRDM14 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX4; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TUMOR MARKER; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; FORKHEAD BOX PROTEIN M1; FOXM1 PROTEIN, HUMAN; TWIST RELATED PROTEIN 1;

APOPTOSIS; CANCER STEM CELL; CELL CYCLE REGULATION; CELL MIGRATION; CONTACT INHIBITION; DNA REPAIR; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HEMATOLOGIC MALIGNANCY; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SOLID TUMOR; TUMOR INVASION; CELL CYCLE; HEMATOLOGIC DISEASE; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL CYCLE; DNA REPAIR; EPITHELIAL-MESENCHYMAL TRANSITION; FORKHEAD BOX PROTEIN M1; HEMATOLOGIC NEOPLASMS; HUMANS; NEOPLASMS; POLYCOMB REPRESSIVE COMPLEX 1; SIGNAL TRANSDUCTION; SNAIL FAMILY TRANSCRIPTION FACTORS; TWIST-RELATED PROTEIN 1;

EID: 84983200525     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2015.05.002     Document Type: Review

References (100)

1. Nieto M.A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 2013, 342:1234850.
2. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
3. Pijnenborg R., Dixon G., Robertson W.B., Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980, 1:3-19.
4. The neural crest 1999, CambridgeUniversityPress, Cambridge, MA. N. LeDouarin, C. Kalcheim (Eds.).
5. Johansson K.A., Grapin-Botton A. Development and diseases of the pancreas. Clin Genet 2002, 62:14-23.
6. Tanimizu N., Miyajima A. Molecular mechanism of liver development and regeneration. Int Rev Cytol 2007, 259:1-48.
7. Nakajima Y., Yamagishi T., Hokari S., Nakamura H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec 2000, 258:119-127.
8. Arnoux V., Nassour M., L'Helgoualc'h A., Hipskind R.A., Savagner P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell 2008, 19:4738-4749.
9. Ahmed N., Maines-Bandiera S., Quinn M.A., Unger W.G., Dedhar S., Auersperg N. Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 2006, 290:C1532-C1542.
10. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002, 110:341-350.
11. Nitta T., Kim J.S., Mohuczy D., Behrns K.E. Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology 2008, 48:909-919.
12. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007, 13:952-961.
13. Strippoli R., Benedicto I., Pérez Lozano M.L., Cerezo A., López-Cabrera M., del Pozo M.A. Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis Model Mech 2008, 1:264-274.
14. Tarin D., Thompson E.W., Newgreen D.F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005, 65:5996-6000.
15. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006, 66:8319-8326.
16. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007, 50:151-162.
17. Vasko V., Espinosa A.V., Scouten W., He H., Auer H., Liyanarachchi S., et al. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A 2007, 104:2803-2808.
18. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer 2007, 7:415-428.
19. Wang X., Zheng M., Liu G., Xia W., McKeown-Longo P.J., Hung M.C., et al. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res 2007, 67:7184-7193.
20. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008, 14:818-829.
21. Sobrado V.R., Moreno-Bueno G., Cubillo E., Holt L.J., Nieto M.A., Portillo F., et al. The class I bHLH factors E2-2A and E2-2B regulate EMT. J Cell Sci 2009, 122:1014-1024.
22. Blanco M.J., Moreno-Bueno G., Sarrio D., Locascio A., Cano A., Palacios J., et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002, 21:3241-3246.
23. Herranz N., Pasini D., Díaz V.M., Francí C., Gutierrez A., Dave N., et al. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol Cell Biol 2008, 28:4772-4781.
24. Batlle E., Sancho E., Francí C., Domínguez D., Monfar M., Baulida J., et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000, 2:84-89.
25. Peinado H., Ballestar E., Esteller M., Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004, 24:306-319.
26. Evdokimova V., Tognon C., Ng T., Ruzanov P., Melnyk N., Fink D., et al. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009, 15:402-415.
27. Yamashita S., Miyagi C., Fukada T., Kagara N., Che Y.S., Hirano T. Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 2004, 429:298-302.
28. Yang Z., Rayala S., Nguyen D., Vadlamudi R.K., Chen S., Kumar R. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res 2005, 65:3179-3184.
29. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004, 6:931-940.
30. Peinado H., Portillo F., Cano A. Switching on-off Snail: LOXL2 versus GSK3beta. Cell Cycle 2005, 4:1749-1752.
31. Vincent T., Neve E.P., Johnson J.R., Kukalev A., Rojo F., Albanell J., et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 2009, 11:943-950.
32. Guaita S., Puig I., Franci C., Garrido M., Dominguez D., Batlle E., et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002, 277:39209-39216.
33. Peña C., García J.M., García V., Silva J., Domínguez G., Rodríguez R., et al. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. Int J Cancer 2006, 119:2098-2104.
34. Mironchik Y., Winnard P.T., Vesuna F., Kato Y., Wildes F., Pathak A.P., et al. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 2005, 65:10801-10809.
35. Kyo S., Sakaguchi J., Ohno S., Mizumoto Y., Maida Y., Hashimoto M., et al. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006, 37:431-438.
36. Lee T.K., Poon R.T., Yuen A.P., Ling M.T., Kwok W.K., Wang X.H., et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006, 12:5369-5376.
37. Hoek K., Rimm D.L., Williams K.R., Zhao H., Ariyan S., Lin A., et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004, 64:5270-5282.
38. Casas E., Kim J., Bendesky A., Ohno-Machado L., Wolfe C.J., Yang J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 2011, 71:245-254.
39. Smit M.A., Geiger T.R., Song J.Y., Gitelman I., Peeper D.S. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 2009, 29:3722-3737.
40. Šošić D., Richardson J.A., Yu K., Ornitz D.M., Olson E.N. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 2003, 112:169-180.
41. Qin L., Liu Z., Chen H., Xu J. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res 2009, 69:3819-3827.
42. Cheng G.Z., Chan J., Wang Q., Zhang W., Sun C.D., Wang L.H. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007, 67:1979-1987.
43. Martin T.A., Goyal A., Watkins G., Jiang W.G. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005, 12:488-496.
44. Huang K.T., Dobrovic A., Yan M., Karim R.Z., Lee C.S., Lakhani S.R., et al. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast. Breast Cancer Res Treat 2010, 124:555-565.
45. Vesuna F., Lisok A., Kimble B., Domek J., Kato Y., van der Groep P., et al. Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α. Oncogene 2012, 31:3223-3234.
46. Yang M.H., Hsu D.S., Wang H.W., Wang H.J., Lan H.Y., Yang W.H., et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010, 12:982-992.
47. Piccinin S., Tonin E., Sessa S., Demontis S., Rossi S., Pecciarini L., et al. A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. Cancer Cell 2012, 22:404-415.
48. Vesuna F., Lisok A., Kimble B., Raman V. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 2009, 11:1318-1328.
49. Li J., Zhou B.P. Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 2011, 11:49.
50. Shiota M., Yokomizo A., Itsumi M., Uchiumi T., Tada Y., Song Y., et al. Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells. BJU Int 2011, 108:E142-E149.
51. Saxena M., Stephens M.A., Pathak H., Rangarajan A. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis 2011, 2:e179.
52. Nie L., Xu M., Vladimirova A., Sun X.H. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J 2003, 22:5780-5792.
53. Chu C., Kohtz D.S. Identification of the E2A gene products as regulatory targets of the G1 cyclin-dependent kinases. J Biol Chem 2001, 276:8524-8534.
54. + compartment represents a novel prognostic factor in chronic myeloid leukemia. Blood 2011, 117:1673-1676.
55. Bowles J., Schepers G., Koopman P. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 2000, 227:239-255.
56. Dy P., Penzo-Méndez A., Wang H., Pedraza C.E., Macklin W.B., Lefebvre V. The three SoxC proteins-Sox4, Sox11 and Sox12-exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res 2008, 36:3101-3117.
57. Schilham M.W., Oosterwegel M.A., Moerer P., Ya J., de Boer P.A., van de Wetering M., et al. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 1996, 380:711-714.
58. Kuwahara M., Yamashita M., Shinoda K., Tofukuji S., Onodera A., Shinnakasu R., et al. The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses T(H)2 differentiation. Nat Immunol 2012, 13:778-786.
59. van de Wetering M., Oosterwegel M., van Norren K., Clevers H. Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J 1993, 12:3847-3854.
60. Deneault E., Cellot S., Faubert A., Laverdure J.P., Fréchette M., Chagraoui J., et al. A functional screen to identify novel effectors of hematopoietic stem cell activity. Cell 2009, 137:369-379.
61. Suzuki T., Shen H., Akagi K., Morse H.C., Malley J.D., Naiman D.Q., et al. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002, 32:166-174.
62. Shin M.S., Fredrickson T.N., Hartley J.W., Suzuki T., Akagi K., Morse H.C. High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res 2004, 64:4419-4427.
63. Sandoval S., Kraus C., Cho E.C., Cho M., Bies J., Manara E., et al. Sox4 cooperates with CREB in myeloid transformation. Blood 2012, 120:155-165.
64. Novershtern N., Subramanian A., Lawton L.N., Mak R.H., Haining W.N., McConkey M.E., et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 2011, 144:296-309.
65. Zhang J., Liang Q., Lei Y., Yao M., Li L., Gao X., et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res 2012, 72:4597-4608.
66. Ikushima H., Todo T., Ino Y., Takahashi M., Saito N., Miyazawa K., et al. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein. J Biol Chem 2011, 286:41434-41441.
67. Chetty C., Dontula R., Gujrati M., Dinh D.H., Lakka S.S. Blockade of SOX4 mediated DNA repair by SPARC enhances radioresponse in medulloblastoma. Cancer Lett 2012, 323:188-198.
68. Park I.K., Morrison S.J., Clarke M.F. Bmi1, stem cells, and senescence regulation. J Clin Invest 2004, 113:175-179.
69. Huber G.F., Albinger-Hegyi A., Soltermann A., Roessle M., Graf N., Haerle S.K., et al. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer 2011, 117:4659-4670.
70. Dimri G.P., Martinez J.L., Jacobs J.J., Keblusek P., Itahana K., Van Lohuizen M., et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 2002, 62:4736-4745.
71. Raaphorst F.M. Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum Mol Genet 2005, 14:R93-R100.
72. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423:255-260.
73. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999, 397:164-168.
74. Crea F., Duhagon Serrat M.A., Hurt E.M., Thomas S.B., Danesi R., Farrar W.L. BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer. Int J Cancer 2011, 128:1946-1954.
75. Li J., Gong L.Y., Song L.B., Jiang L.L., Liu L.P., Wu J., et al. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am J Pathol 2010, 176:699-709.
76. Song L.B., Li J., Liao W.T., Feng Y., Yu C.P., Hu L.J., et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009, 119:3626-3636.
77. Lee K., Adhikary G., Balasubramanian S., Gopalakrishnan R., McCormick T., Dimri G.P., et al. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol 2008, 128:9-17.
78. Hosokawa H., Kimura M.Y., Shinnakasu R., Suzuki A., Miki T., Koseki H., et al. Regulation of Th2 cell development by Polycomb group gene bmi-1 through the stabilization of GATA3. J Immunol 2006, 177:7656-7664.
79. Carlsson P., Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol 2002, 250:1-23.
80. Lai E., Clark K.L., Burley S.K., Darnell J.E. Hepatocyte nuclear factor 3/fork head or "winged helix" proteins: a family of transcription factors of diverse biologic function. Proc Natl Acad Sci U S A 1993, 90:10421-10423.
81. Green M.R., Aya-Bonilla C., Gandhi M.K., Lea R.A., Wellwood J., Wood P., et al. Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes Cancer 2011, 50:313-326.
82. Ma R.Y., Tong T.H., Cheung A.M., Tsang A.C., Leung W.Y., Yao K.M. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 2005, 118:795-806.
83. Wang I.C., Chen Y.J., Hughes D., Petrovic V., Major M.L., Park H.J., et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 2005, 25:10875-10894.
84. Bao B., Wang Z., Ali S., Kong D., Banerjee S., Ahmad A., et al. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 2011, 112:2296-2306.
85. Katoh M., Igarashi M., Fukuda H., Nakagama H., Katoh M. Cancer genetics and genomics of human FOX family genes. Cancer Lett 2013, 328:198-206.
86. Ahmad A., Wang Z., Kong D., Ali S., Li Y., Banerjee S., et al. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat 2010, 122:337-346.
87. Streubel B., Vinatzer U., Lamprecht A., Raderer M., Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005, 19:652-658.
88. Goatly A., Bacon C.M., Nakamura S., Ye H., Kim I., Brown P.J., et al. FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. Mod Pathol 2008, 21:902-911.
89. Barrans S.L., Fenton J.A., Banham A., Owen R.G., Jack A.S. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 2004, 104:2933-2935.
90. Han S.L., Wu X.L., Wan L., Zeng Q.Q., Li J.L., Liu Z. FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas. Dig Surg 2009, 26:156-162.
91. Hu H., Wang B., Borde M., Nardone J., Maika S., Allred L., et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol 2006, 7:819-826.
92. Mani S.A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., et al. Mesenchyme forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A 2007, 104:10069-10074.
93. Zhang H., Meng F., Liu G., Zhang B., Zhu J., Wu F., et al. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res 2011, 71:1292-1301.
94. Kim K.C., Geng L., Huang S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 2003, 63:7619-7623.
95. Tsuneyoshi N., Sumi T., Onda H., Nojima H., Nakatsuji N., Suemori H. PRDM14 suppresses expression of differentiation marker genes in human embryonic stem cells. Biochem Biophys Res Commun 2008, 367:899-905.
96. Chia N.Y., Chan Y.S., Feng B., Lu X., Orlov Y.L., Moreau D., et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 2010, 468:316-320.
97. Dettman E.J., Simko S.J., Ayanga B., Carofino B.L., Margolin J.F., Morse H.C., et al. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors. Oncogene 2011, 30:2859-2873.
98. Chase M.B., Fu S., Haga S.B., Davenport G., Stevenson H., Do K., et al. BP1, a homeodomain-containing isoform of DLX4, represses the beta-globin gene. Mol Cell Biol 2002, 22:2505-2514.
99. Haga S.B., Fu S., Karp J.E., Ross D.D., Williams D.M., Hankins W.D., et al. BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia 2000, 14:1867-1875.
100. Zhang L., Yang M., Gan L., He T., Xiao X., Stewart M.D., et al. DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis. Int J Biol Sci 2012, 8:1178-1187.